Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
SAIL reported its quarterly results on October 14, and what has followed is a stock that slipped 1% on the day to $19.37, down nearly 3% on the week, even as the bull case on identity security remains firmly intact after a print that showed 17% revenue growth and ARR climbing to $1.23 billion.
Short interest has made its most notable move of the past month. Positions jumped roughly 21% over the week to reach 4.5% of free float, a rise that began sharply around October 8 when short shares climbed from roughly 20.7 million to over 25 million. That is the highest level in the 30-day history available and follows a period in early October where availability had tightened to just 29% before easing back to 56% by October 13. At 56% availability, the borrow market is moderate rather than stressed, with borrowing costs running below 0.9%, their lowest in a month. The options market is running slightly more cautious than usual. The put/call ratio has settled at 0.64, about one standard deviation above its 20-day average of 0.50, not an extreme reading but consistent with investors buying incremental downside protection through and after the earnings date. The ORTEX short score hit 74.7 on October 12, a multi-week high, and ranks in the bottom 4th percentile of the universe on short score, reflecting the accumulation of short-side signals.
The Street is broadly constructive, but the bullish consensus sits awkwardly against a stock that has barely moved post-print. The mean analyst price target now stands at $21.88, roughly 13% above the current price. Cantor Fitzgerald raised its target to $27 from $25 on October 9 while keeping its Overweight rating. Baird lifted to $25 from $22. Oppenheimer, which initiated coverage last week at Outperform with a $30 target, is the most ambitious voice on the Street. The bull case centres on SailPoint's identity graph, its SaaS transition and an AI-driven ARR that reached $70 million. Bears counter that the core IGA market is approaching saturation, the newer AI opportunity generated only about $21 million of net new ARR last quarter, and the stock trades at 8x forward EV/revenue against a 7.3x peer mean, leaving limited room for disappointment. EV/EBITDA has drifted down roughly 0.93 points over 30 days to 35.4x, a modest de-rating. The analyst recommendation differential ranks in the 97th percentile of the universe, meaning the gap between positive and neutral/negative ratings is wider than almost any other stock, a sign of genuine conviction but also of a crowded bullish view.
The ownership structure creates its own gravitational pull. Thoma Bravo controls 84% of shares outstanding, which means the tradeable float is small. Mark McClain, the CEO, holds a further 1.4% of shares. That concentration explains why short interest at 4.5% of free float can feel more consequential than the headline percentage implies. On the insider side, a cluster of executives sold shares on October 7, all under pre-arranged 10b5-1 plans. McClain sold 114,913 shares for roughly $2.3 million. The Chief Accounting Officer, General Counsel and two other C-suite names also filed sales. Because every trade was pre-planned, the signal value is limited, but the 90-day net insider position across all transactions runs to minus $10.2 million, a meaningful tally even if the mechanics are scheduled rather than discretionary.
The earnings history offers limited precedent. The most recent comparable print, on September 9, produced a 0.8% drop on the day followed by a 14% rally over the subsequent five sessions. The next quarterly report is scheduled for December 10. Between now and then, the focus shifts to whether the $70 million AI ARR line accelerates meaningfully enough to change the valuation argument, and whether the sharp one-week short rebuild is a positioning reset after the earnings event or the start of a more sustained bearish thesis.
See the live data behind this article on ORTEX.
Open SAIL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
